Express News | Boston Scientific Watchman Flx™ Left Atrial Appendage Closure Device Demonstrates Superior Bleeding Risk Reduction to Oral Anticoagulation Following a Cardiac Ablation in the Option Clinical Trial
Boston Scientific WATCHMAN FLX Left Atrial Appendage Closure Device Demonstrates Superior Bleeding Risk Reduction to Oral Anticoagulation Following a Cardiac Ablation in the OPTION Clinical Trial
News On Axonics Inc. (AXNX) Now Under BSX
Boston Scientific Corporation (BSX) UBS Global Healthcare Conference (Transcript)
Boston Scientific Closes Acquisition of Axonics, Inc.
Express News | Viking Global Investors LP Cuts Share Stake in T-Mobile US Inc by 53.8% to 1.2 Mln Shares